Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

When it comes to losing fat without extreme exercise, only a few medicines are worth considering. With the innovation in the medical world, physicians are now recommending the Ozempic weight loss ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Research has found that GLP-1 receptors, found in medications like Wegovy and Monjaro, may offer health benefits beyond the ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

No, it’s not ‘brat’, ‘demure’, or even ‘brain rot’; it’s Ozempic. The drug has become increasingly popular for helping people (including your favourite celebrities) lose weight ...

Semaglutide, the active ingredient in Ozempic and Wegovy, may top the list of medications. Other possible candidates include the breast cancer drug Ibrance, Trelegy, an asthma treatment ...

Gift 5 articles to anyone you choose each month when you subscribe. Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for obese Australians without ...

Bloomberg Eli Lilly is expected to lodge a submission to have Mounjaro, which competes with Ozempic as one of the world’s most popular weight-loss drugs, listed on the PBS mid-next year ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...